COST-EFFECTIVENESS ANALYSIS OF THROMBOLYSIS WITH RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR (ALTEPLASE) FOR ACUTE ISCHEMIC STROKE UNDER THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM PERSPECTIVE

被引：0
|
作者：
Teich, V [1 ]
Passos, R. B. F. [1 ]
Vianna, D. [2 ]
机构：
[1] MedInsight, Rio De Janeiro, Brazil
[2] Univ Rio de Janeiro, Rio De Janeiro, Brazil
来源：
VALUE IN HEALTH | 2009年 / 12卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(10)75381-X
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A503 / A503
页数：1
相关论文
共 50 条
  • [41] Cost-Effectiveness of Intra-Arterial Treatment as an Adjunct to Intravenous Tissue-Type Plasminogen Activator for Acute Ischemic Stroke
    Leppert, Michelle H.
    Campbell, Jonathan D.
    Simpson, Jennifer R.
    Burke, James F.
    STROKE, 2015, 46 (07) : 1870 - 1876
  • [42] A Model of Cost-effectiveness of Tissue Plasminogen Activator in Patient Subgroups 3 to 4.5 Hours After Onset of Acute Ischemic Stroke
    Boudreau, Denise M.
    Guzauskas, Greg
    Villa, Kathleen F.
    Fagan, Susan C.
    Veenstra, David L.
    ANNALS OF EMERGENCY MEDICINE, 2013, 61 (01) : 46 - 55
  • [43] Cost-effectiveness analysis of endovascular treatment with or without intravenous thrombolysis in acute ischemic stroke
    Qureshi, Adnan, I
    Akinci, Yasemin
    Huang, Wei
    Ishfaq, Muhammad F.
    Hassan, Ameer E.
    Siddiq, Farhan
    Gomez, Camilo R.
    JOURNAL OF NEUROSURGERY, 2023, 138 (01) : 223 - 232
  • [44] Endovascular Thrombectomy with or without Bridging Thrombolysis in Acute Ischemic Stroke: A Cost-Effectiveness Analysis
    Morsi, Rami Z.
    Zhang, Yuan
    Zhu, Meng
    Xie, Shitong
    Carrion-Penagos, Julian
    Desai, Harsh
    Tannous, Elie
    Kothari, Sachin A.
    Khamis, Assem
    Darzi, Andrea J.
    Tarabichi, Ammar
    Bastin, Reena
    Hneiny, Layal
    Thind, Sonam
    Siegler, James E.
    Coleman, Elisheva R.
    Mendelson, Scott J.
    Mansour, Ali
    Prabhakaran, Shyam
    Kass-Hout, Tareq
    NEUROEPIDEMIOLOGY, 2024, 58 (01) : 47 - 56
  • [45] HEALTH EQUITY IMPACTS OF ALTEPLASE FOR ISCHEMIC STROKE IN THE UNITED STATES: A DISTRIBUTIONAL COST-EFFECTIVENESS ANALYSIS
    Majda, T.
    Kowal, S.
    Mearns, E. S.
    Purdon, B.
    VALUE IN HEALTH, 2024, 27 (06) : S4 - S4
  • [46] RUPTURE OF AN OCCULT INTRACRANIAL MYCOTIC ANEURYSM AFTER INTRAVENOUS THROMBOLYSIS WITH RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR FOR ACUTE ISCHEMIC STROKE
    Glenn, Jared
    Strecker-McGraw, Margaret
    McGraw, Ian
    Jabbar, Karim
    James, Nathan A.
    Stone, C. Keith
    JOURNAL OF EMERGENCY MEDICINE, 2017, 53 (05): : 717 - 721
  • [47] Left ventricular apical thrombus after systemic thrombolysis with recombinant tissue plasminogen activator in a patient with acute ischemic stroke
    Doepp F.
    Sanad W.
    Schreiber S.J.
    Baumann G.
    Borges A.C.
    Cardiovascular Ultrasound, 3 (1)
  • [48] Baseline computed tomography changes and clinical outcome after thrombolysis with recombinant tissue plasminogen activator in acute ischemic stroke
    Mendizabal, JE
    Lurie, DN
    Greiner, FG
    Shah, AK
    Zweifler, RM
    JOURNAL OF NEUROIMAGING, 2001, 11 (02) : 101 - 104
  • [49] Cost-effectiveness of insulin analogs from the perspective of the Brazilian public health system
    Cazarim, Maurilio de Souza
    Vilela Rodrigues, Joao Paulo
    Coelho da Cruz-Cazarim, Estael Luzia
    Ayres, Lorena Rocha
    Leira Pereira, Leonardo Regis
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 53 (03)
  • [50] Cost-Utility of Intravenous Recombinant Tissue Plasminogen Activator in the Treatment of Acute Ischemic Stroke: a Systematic Review
    Niknam, Kian
    Dollar, Krista
    Pellegrini, Eric
    Kim, Anthony
    STROKE, 2018, 49
12345